Home » Business News » 2013 » May » May 13, 2013

NiCOX FEATURED ARTICLE: Presentations at ARVO 2013 Annual Meeting

May 13, 2013 - Sophia Antipolis Cedex, France


Nicox: Presentations at ARVO 2013 Annual Meeting

May 13, 2013.

Nicox presented two scientific posters at the Association for Research inVision and Ophthalmology (ARVO) Annual Meeting, which took place from May 5to May 9 in Seattle, Washington. The posters reported research results onthe role of nitric oxide (NO) in the physiology of the eye and morespecifically in the regulation of intraocular pressure (IOP).

Read more:

Read about our nitric oxide programs in ophthalmology:

* NO-donating steroids
* Next generation NO-donors
* Latanoprostene bunod (previously know as BOL-303259-X)

This featured article may contains certain forward-looking statements.Although the Company believes its expectations are based on reasonableassumptions, these forward-looking statements are subject to numerous risksand uncertainties, which could cause actual results to differ materiallyfrom those anticipated in the forward-looking statements.

Risks factors which are likely to have a material effect on Nicox'sbusiness are presented in the 4th chapter of the "Document de reference,rapport financier annuel et rapport de gestion 2012" filed with the FrenchAutorite des Marchés Financiers (AMF) on March 22, 2013 and available onNicox's website ( and on the AMF's website

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: NICOX via Thomson Reuters ONE


Nicox Contacts
Corporate Communications
Tel +33 (0)4 97 24 53 00
Email Contact

Nicox S.A.
Drakkar 2 | Bat D | 2405 route des Dolines | CS 10313 | Sophia Antipolis |
06560 Valbonne | France
T: +33 (0)4 97 24 53 00
F: +33 (0)4 97 24 53 99


Comment on this story